Clinical Trial Update: Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing acetylsalicylic acid to placebo in high-risk individuals with subsolid lung nodules; trial completed with results posted in 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer Precursor Conditions
• Subsolid Lung Nodules

Drugs mentioned

• Acetylsalicylic acid (Aspirin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Current Smoker, Former Smoker | Phase 2 | Status: COMPLETED | Results posted: 2020-05-21